Results
|
21.
|
|
|
22.
|
|
|
23.
|
|
|
24.
|
|
|
25.
|
|
|
26.
|
|
|
27.
|
|
|
28.
|
|
|
29.
|
|
|
30.
|
|
|
31.
|
Preclinical safety of topically administered nanostructured lipid carriers (NLC) for wound healing application: biodistribution and toxicity studies. [electronic resource] by
- Vairo, C
- Collantes, M
- Quincoces, G
- Villullas, S
- Peñuelas, I
- Pastor, M
- Gil, A G
- Gainza, E
- Hernandez, R M
- Igartua, M
- Gainza, G
Producer: 20200129
In:
International journal of pharmaceutics vol. 569
Availability: No items available.
|
|
32.
|
Topographical Distribution of Morphological Changes in a Partial Model of Parkinson's Disease--Effects of Nanoencapsulated Neurotrophic Factors Administration. [electronic resource] by
- Requejo, C
- Ruiz-Ortega, J A
- Bengoetxea, H
- Garcia-Blanco, A
- Herrán, E
- Aristieta, A
- Igartua, M
- Ugedo, L
- Pedraz, J L
- Hernández, R M
- Lafuente, J V
Producer: 20160621
In:
Molecular neurobiology vol. 52
Availability: No items available.
|
|
33.
|
Morphological Changes in a Severe Model of Parkinson's Disease and Its Suitability to Test the Therapeutic Effects of Microencapsulated Neurotrophic Factors. [electronic resource] by
- Requejo, C
- Ruiz-Ortega, J A
- Bengoetxea, H
- García-Blanco, A
- Herrán, E
- Aristieta, A
- Igartua, M
- Pedraz, J L
- Ugedo, L
- Hernández, R M
- Lafuente, J V
Producer: 20180702
In:
Molecular neurobiology vol. 54
Availability: No items available.
|